Benefits
Capillary Strength Support (Traditional Use)
Traditionally combined with vitamin C for capillary fragility and easy bruising. The proposed mechanism is reduced capillary permeability, shared with other citrus bioflavonoids. This is historical structure-function use: there are no direct trials of plain rutin measuring bruising or bleeding outcomes.
Venous Insufficiency Adjunct
Rutin (especially as O-(beta-hydroxyethyl)-rutoside / oxerutins / Venoruton®) used for chronic venous insufficiency in Europe. The controlled venous-insufficiency evidence here is for the oxerutin derivative, not for plain dietary rutin.
Antioxidant Activity
Direct free radical scavenging plus quercetin-like effects after gut hydrolysis to active aglycone. Broad antioxidant profile contributing to cardiovascular and longevity applications.
Anti-Inflammatory Signals (Biomarker Only)
In laboratory models rutin reduces inflammatory cytokine signaling and NF-kB activation. The only human signal is a lower IL-6 level in one small (50-patient) diabetes trial, a biomarker rather than a measured clinical inflammatory outcome.
Use in Combination Allergy Formulas (Uncited)
Rutin is sometimes combined with luteolin and quercetin in multi-ingredient allergy and mast-cell formulas. This is combination-product use: no trial has tested plain rutin for mast-cell or allergic outcomes in people.
Mechanism of action
Quercetin Prodrug
Rutin is a glycoside that gets hydrolyzed by gut microbiome to release quercetin (the active aglycone) plus rutinose. Functionally a delayed-release/colon-targeted quercetin source. Bioavailability and tissue distribution differ from free quercetin.
Capillary Permeability Reduction
Decreases capillary leakage — improves capillary integrity. Foundational mechanism for 'bioflavonoid' applications in capillary fragility.
Antioxidant via Free Radical Scavenging
Direct antioxidant activity plus iron-chelating activity. Inhibits lipid peroxidation.
Synergy with Vitamin C
Vitamin C and rutin (and other bioflavonoids) work synergistically — flavonoids stabilize vitamin C by reducing oxidation. Basis for traditional 'vitamin C with bioflavonoids' formulations.
Clinical trials
Multiple RCTs of hydroxyethylrutosides / oxerutins (Venoruton®) for chronic venous insufficiency.
CVI patients across multiple trials.
Oxerutins, a semi-synthetic hydroxyethyl derivative of rutin sold as Venoruton, significantly reduce CVI symptoms such as edema, pain, and leg heaviness. This evidence is for the derivative, which is absorbed differently and has different pharmacokinetics from plain dietary rutin, and it does not transfer to plain rutin.
Double-blind multicenter trial of a five-flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) versus a diosmin-based comparator mixture. No placebo arm.
154 patients with degree I to III hemorrhoidal disease.
Bleeding improved similarly in both arms (about 80 percent at 1 month) with no significant difference between the five-flavonoid mixture and the diosmin-based comparator. Rutin was one of five components and not the dominant one, so the benefit cannot be attributed to plain rutin, and there was no placebo group.